top of page
it's where dermatology lives
![DERM. CITY 2 copy.png](https://static.wixstatic.com/media/cabd8d_a4e332a5f50840f6a64e29150b052324~mv2.png/v1/fill/w_243,h_243,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/DERM_%20CITY%202%20copy.png)
EADV Congress 2023
Live Video Reports
![Untitled design (4).png](https://static.wixstatic.com/media/cabd8d_1ef8517e473541f792d0b8654ac62964~mv2.png/v1/fill/w_198,h_198,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Untitled%20design%20(4).png)
live at
![eadv-congress_logo-1536x405.png](https://static.wixstatic.com/media/cabd8d_6d2304b8e5a84bb98396d21ba7e25282~mv2.png/v1/fill/w_398,h_101,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/eadv-congress_logo-1536x405.png)
Derm.City presents thrice-daily reports from key opinion leaders in dermatology live from the EADV Congress 2023 in Berlin.
EADV 2023 Day 1 Morning:
The Pathogenesis of Psoriasis
EADV 2023 Day 1 Afternoon:
Late Breaking HS and Alopecia Developments
EADV 2023 Day 1 Evening:
Late Breakers in Atopic Dermatitis
EADV 2023 Day 2 Morning:
Late Breaking Psoriasis Presentations
EADV 2023 Day 2 Afternoon:
Treating Severe Atopic Dermatitis with Tapinarof 1% Cream
EADV 2023 Day 2 Evening:
Molecular Signature of Chronic Hand Eczema
EADV 2023 Day 3 Morning:
Bullous Diseases
EADV 2023 Day 3 Afternoon:
Efficacy and Safety of Rezpegaldesleukin
EADV 2023 Day 3 Evening:
Abrocitinib for Prurigo Nodularis in Chronic Pruritis
EADV 2023 Day 4 Morning:
Congress Presentations of Interest
EADV 2023 Day 4 Afternoon:
JAK Inhibitors and Inflammatory Skin Disease
EADV 2023 Special Report:
Long-Term Deucravacitinib Treatment for Plaque Psoriasis
bottom of page